Home

STEPHEN C MCCLUSKI

CIK 1188728 · Senior Vice President · last filed 2025-08-13

STEPHEN C MCCLUSKI is a Senior Vice President who has filed 63 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MNRO, was dated Aug 13, 2025. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $372.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$372.3K

Companies

5

Total Filings

63

Lifetime Open-Market Net

-$1.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MNRO Director 31,928 $11.66 $372.3K -$1.86M 17 2025-08-13
ImmunoGen, Inc. (IMGN) Delisted Director 0 $31.23 $0 $0 20 2024-02-12
STANDARD MICROSYSTEMS CORP (SMSC) Delisted Director 4,867 — — $0 17 2012-07-18
IDEV Director 0 $92.97 $0 $0 3 2009-02-25
BAUSCH & LOMB INC (BOL) Delisted Senior Vice President 26,049 — — $0 4 2007-05-10

Recent Filings

63 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-08-13 MNRO Grant (A) +8,306 $0 EDGAR
2024-08-15 MNRO Grant (A) +4,937 $0 EDGAR
2024-02-12 ImmunoGen, Inc. (IMGN) Delisted Disp (D) — $0 EDGAR
2023-09-14 ImmunoGen, Inc. (IMGN) Delisted Exer (M) — -$13.5K EDGAR
2023-09-13 — Notice (144) −10,000 -$160.5K EDGAR
2023-08-17 MNRO Grant (A) +3,749 $0 EDGAR
2023-06-16 ImmunoGen, Inc. (IMGN) Delisted Grant (A) — $0 EDGAR
2022-08-18 MNRO Grant (A) +2,426 $0 EDGAR
2022-06-17 ImmunoGen, Inc. (IMGN) Delisted Grant (A) — $0 EDGAR
2021-08-19 MNRO Grant (A) +2,351 $0 EDGAR
Showing 1–10 of 63
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.